Prostate cancer metastases had even lower SSTR2 expression values than primary prostate cancers (109.5±67.4 [primaries] vs. 55.4±23.9 [metastases], p = 0.0011, Figure 3D). Here, SSTR2 is linked to prostate carcinoma.